These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Increased C-X-C Motif Chemokine Ligand 12 Levels in Cerebrospinal Fluid as a Candidate Biomarker in Sporadic Amyotrophic Lateral Sclerosis. Andrés-Benito P; Povedano M; Domínguez R; Marco C; Colomina MJ; López-Pérez Ó; Santana I; Baldeiras I; Martínez-Yelámos S; Zerr I; Llorens F; Fernández-Irigoyen J; Santamaría E; Ferrer I Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33213069 [TBL] [Abstract][Full Text] [Related]
8. alpha-Tocopherol quinone level is remarkably low in the cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Tohgi H; Abe T; Saheki M; Yamazaki K; Takahashi S Neurosci Lett; 1996 Mar; 207(1):5-8. PubMed ID: 8710208 [TBL] [Abstract][Full Text] [Related]
9. Increase in oxidized NO products and reduction in oxidized glutathione in cerebrospinal fluid from patients with sporadic form of amyotrophic lateral sclerosis. Tohgi H; Abe T; Yamazaki K; Murata T; Ishizaki E; Isobe C Neurosci Lett; 1999 Feb; 260(3):204-6. PubMed ID: 10076903 [TBL] [Abstract][Full Text] [Related]
10. Biotransformation of nitric oxide in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Kokić AN; Stević Z; Stojanović S; Blagojević DP; Jones DR; Pavlović S; Niketić V; Apostolski S; Spasić MB Redox Rep; 2005; 10(5):265-70. PubMed ID: 16354415 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-12 and interferon-gamma are not detectable in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Ford L; Rowe D Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Jun; 5(2):118-20. PubMed ID: 15204013 [TBL] [Abstract][Full Text] [Related]
12. In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses. Fiszman ML; Ricart KC; Latini A; Rodríguez G; Sica RE Acta Neurol Scand; 2010 Feb; 121(2):120-6. PubMed ID: 19804473 [TBL] [Abstract][Full Text] [Related]
13. Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease. Tohgi H; Abe T; Yamazaki K; Murata T; Ishizaki E; Isobe C Neurosci Lett; 1999 Jul; 269(1):52-4. PubMed ID: 10821643 [TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid levels of alpha-tocopherol in amyotrophic lateral sclerosis. de Bustos F; Jiménez-Jiménez FJ; Molina JA; Esteban J; Guerrero-Sola A; Zurdo M; Ortí-Pareja M; Tallón-Barranco A; Gómez-Escalonilla C; Ramírez-Ramos C; Arenas J; Enríquez de Salamanca R J Neural Transm (Vienna); 1998; 105(6-7):703-8. PubMed ID: 9826112 [TBL] [Abstract][Full Text] [Related]
15. Expression of vesicle-associated membrane-protein-associated protein B cleavage products in peripheral blood leukocytes and cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Deidda I; Galizzi G; Passantino R; Cascio C; Russo D; Colletti T; La Bella V; Guarneri P Eur J Neurol; 2014 Mar; 21(3):478-85. PubMed ID: 24372953 [TBL] [Abstract][Full Text] [Related]
16. Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Jiménez-Jiménez FJ; Hernánz A; Medina-Acebrón S; de Bustos F; Zurdo JM; Alonso H; Puertas I; Barcenilla B; Sayed Y; Cabrera-Valdivia F Acta Neurol Scand; 2005 Feb; 111(2):114-7. PubMed ID: 15644071 [TBL] [Abstract][Full Text] [Related]
17. Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Smith RG; Henry YK; Mattson MP; Appel SH Ann Neurol; 1998 Oct; 44(4):696-9. PubMed ID: 9778272 [TBL] [Abstract][Full Text] [Related]